{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:20:41Z","timestamp":1744777241050,"version":"3.40.4"},"reference-count":41,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.1961","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:24:31Z","timestamp":1741685071000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Nomograms based on clinical factors to predict abnormal metabolism of psychotropic drugs"],"prefix":"10.3892","volume":"22","author":[{"given":"Shuai","family":"Zhou","sequence":"first","affiliation":[{"name":"Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhuo","family":"Si","sequence":"additional","affiliation":[{"name":"Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"key20250415145053_b1-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jama.2020.19048","article-title":"The pharmacologic treatment of schizophrenia-2021","volume":"325","author":"Goff","year":"2021","journal-title":"JAMA"},{"key":"key20250415145053_b2-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1176\/appi.ajp.2017.16091016","article-title":"The long-term effects of antipsychotic medication on clinical course in schizophrenia","volume":"174","author":"Goff","year":"2017","journal-title":"Am J Psychiatry"},{"key":"key20250415145053_b3-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1017\/s003329170400412x","article-title":"The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies","volume":"35","author":"Middeldorp","year":"2005","journal-title":"Psychol Med"},{"key":"key20250415145053_b4-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1016\/j.neuron.2021.09.011","article-title":"Pharmacogenomics: A road ahead for precision medicine in psychiatry","volume":"109","author":"Pardi\u00f1as","year":"2021","journal-title":"Neuron"},{"issue":"642","key":"key20250415145053_b5-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050642","article-title":"Therapeutic drug monitoring in psychiatry: Enhancing treatment precision and patient outcomes","volume":"17","author":"Biso","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20250415145053_b6-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","article-title":"Potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"key":"key20250415145053_b7-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.psychres.2018.12.053","article-title":"Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?","volume":"271","author":"Solomon","year":"2019","journal-title":"Psychiatry Res"},{"issue":"e1003344","key":"key20250415145053_b8-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003344","article-title":"STrengthening the reporting of pharmacogenetic studies: Development of the STROPS guideline","volume":"17","author":"Chaplin","year":"2020","journal-title":"PLoS Med"},{"key":"key20250415145053_b9-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/tpj.2017.21","article-title":"Cost-effectiveness of pharmacogenetic-guided treatment: Are we there yet?","volume":"17","author":"Verbelen","year":"2017","journal-title":"Pharmacogenomics J"},{"issue":"953142","key":"key20250415145053_b10-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.953142","article-title":"Ensuring equity: Pharmacogenetic implementation in rural and tribal communities","volume":"13","author":"Leitch","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20250415145053_b11-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s40262-020-00894-y","article-title":"Pipamperone population pharmacokinetics related to effectiveness and side effects in children and adolescents","volume":"59","author":"Kloosterboer","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"269","key":"key20250415145053_b12-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-03910-6","article-title":"Factors predicting serum clozapine levels in Middle Eastern patients: An observational study","volume":"22","author":"Hassab Errasoul","year":"2022","journal-title":"BMC Psychiatry"},{"key":"key20250415145053_b13-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s40262-020-00969-w","article-title":"Application of physiologically based pharmacokinetic modeling to predict the effect of renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination","volume":"60","author":"Sun","year":"2021","journal-title":"Clin Pharmacokinet"},{"issue":"966622","key":"key20250415145053_b14-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.966622","article-title":"Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20250415145053_b15-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11239-022-02693-7","article-title":"Development and validation of a prediction model of catheter-related thrombosis in patients with cancer undergoing chemotherapy based on ultrasonography results and clinical information","volume":"54","author":"Lin","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"751373","key":"key20250415145053_b16-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.751373","article-title":"The development of nomograms to predict blastulation rate following cycles of in vitro fertilization in patients with tubal factor infertility, polycystic ovary syndrome, or endometriosis","volume":"12","author":"Jin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20250415145053_b17-BR-22-5-01961","first-page":"S1","article-title":"The guidelines for prevention and control of overweight and obesity in Chinese adults","volume":"17 (Suppl)","author":"Chen","year":"2004","journal-title":"Biomed Environ Sci"},{"key":"key20250415145053_b18-BR-22-5-01961"},{"key":"key20250415145053_b19-BR-22-5-01961"},{"key":"key20250415145053_b20-BR-22-5-01961"},{"key":"key20250415145053_b21-BR-22-5-01961"},{"key":"key20250415145053_b22-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ebiom.2017.02.017","article-title":"African genetic diversity: Implications for cytochrome P450-mediated drug metabolism and drug development","volume":"17","author":"Rajman","year":"2017","journal-title":"EBioMedicine"},{"issue":"515606","key":"key20250415145053_b23-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.515606","article-title":"Dual primary cancer patients with lung cancer as a second primary malignancy: A population-based study","volume":"10","author":"Song","year":"2020","journal-title":"Front Oncol"},{"issue":"102924","key":"key20250415145053_b24-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102924","article-title":"Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion","volume":"58","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"key20250415145053_b25-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17425255.2017.1246533","article-title":"Pharmacogenetics of neurological and psychiatric diseases at older age: Has the time come?","volume":"13","author":"Lozupone","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20250415145053_b26-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2217\/pgs.09.56","article-title":"Epigenetic and microRNA-dependent control of cytochrome P450 expression: A gap between DNA and protein","volume":"10","author":"Gomez","year":"2009","journal-title":"Pharmacogenomics"},{"key":"key20250415145053_b27-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1517\/17425255.2015.1041919","article-title":"Measuring pharmacogenetics in special groups: Geriatrics","volume":"11","author":"Seripa","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20250415145053_b28-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1177\/0091270004269647","article-title":"Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects","volume":"44","author":"Bies","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"key20250415145053_b29-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2165\/00023210-200620090-00010","article-title":"Escitalopram: A review of its use in the management of anxiety disorders","volume":"20","author":"Dhillon","year":"2006","journal-title":"CNS Drugs"},{"key":"key20250415145053_b30-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0091270009337946","article-title":"Effect of age, weight, and CYP2C19 genotype on escitalopram exposure","volume":"50","author":"Jin","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"key20250415145053_b31-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol Psychiatry"},{"key":"key20250415145053_b32-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/02698811231152748","article-title":"Associations of antidepressants and antipsychotics with lipid parameters: Do CYP2C19\/CYP2D6 genes play a role? A UK population-based study","volume":"37","author":"Richards-Belle","year":"2023","journal-title":"J Psychopharmacol"},{"key":"key20250415145053_b33-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"1758","key":"key20250415145053_b34-BR-22-5-01961","doi-asserted-by":"publisher","DOI":"10.3390\/genes12111758","article-title":"The influence of CYP2D6 and CYP2C19 genetic variation on diabetes mellitus risk in people taking antidepressants and antipsychotics","volume":"12","author":"Austin-Zimmerman","year":"2021","journal-title":"Genes (Basel)"},{"key":"key20250415145053_b35-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2125.2001.01328.x","article-title":"Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers","volume":"51","author":"H\u00e4gg","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"key20250415145053_b36-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","article-title":"How important are gender differences in pharmacokinetics?","volume":"41","author":"Meibohm","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"key20250415145053_b37-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1097\/HJH.0000000000001006","article-title":"Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults","volume":"34","author":"Maatouk","year":"2016","journal-title":"J Hypertens"},{"key":"key20250415145053_b38-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/acps.12794","article-title":"Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine","volume":"136","author":"Castberg","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"key20250415145053_b39-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2125.2004.02228.x","article-title":"Drug development and use in the elderly: Search for the right dose and dosing regimen (parts I and II)","volume":"58","author":"Shah","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"key20250415145053_b40-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","article-title":"Is depression associated with increased oxidative stress? A systematic review and meta-analysis","volume":"51","author":"Black","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"key20250415145053_b41-BR-22-5-01961","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12291-010-0016-z","article-title":"Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder","volume":"25","author":"Chaudhari","year":"2010","journal-title":"Indian J Clin Biochem"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:50:57Z","timestamp":1744717857000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.1961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,11]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.1961","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"type":"print","value":"2049-9434"},{"type":"electronic","value":"2049-9442"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}